Kaempferol protects melanocytes from ferroptosis by modulating the NF-κB/PTGS2 signaling axis in vitiligo

Xuqing Xu1, Zixian Lei2,3,4, Wen Hu2,3,4

  • 1Graduate School of Xinjiang Medical University, Urumqi, China.

Insights

Kaempferol protects melanocytes from ferroptosis, a cell death mechanism implicated in vitiligo. This study identifies a key signaling pathway involving nuclear factor-κB (NF-κB) and prostaglandin-endoperoxide synthase 2 (PTGS2) that kaempferol modulates to prevent cell damage.

Area of Science:

  • Dermatology
  • Cell Biology
  • Pharmacology

Background:

  • Ferroptosis, a form of oxidative stress-induced cell death, contributes to melanocyte loss in vitiligo.
  • The signaling pathways linking inflammation to ferroptosis in melanocytes are not fully understood.
  • Kaempferol, a flavonoid from Vernonia anthelmintica, has antioxidant and anti-inflammatory properties, but its role in melanocyte ferroptosis is unexplored.

Purpose of the Study:

  • To investigate the protective effects of kaempferol against ferroptosis in human melanocytes.
  • To elucidate the molecular mechanisms underlying kaempferol's action, focusing on inflammatory signaling pathways.
  • To validate the clinical relevance of identified pathways in vitiligo lesions.

Main Methods:

  • Established a ferroptosis model in primary human melanocytes using RSL3 (Ras-selective lethal 3).
  • Integrated transcriptomic profiling, network pharmacology, molecular docking, and immunofluorescence.
  • Validated findings in lesional skin tissues from vitiligo patients.

Main Results:

  • Kaempferol significantly attenuated RSL3-induced ferroptosis markers, including lipid peroxidation and mitochondrial damage.
  • Transcriptomic analysis identified prostaglandin-endoperoxide synthase 2 (PTGS2) as a key node linking nuclear factor-κB (NF-κB) signaling to ferroptosis.
  • Kaempferol inhibited NF-κB activation and subsequent PTGS2 transcription; NF-κB inhibition mimicked kaempferol's protective effects.
  • The NF-κB/PTGS2 pathway and ferroptosis signatures were concurrently activated in vitiligo lesions.

Conclusions:

  • Ferroptosis is a critical mechanism driving melanocyte injury in vitiligo.
  • An NF-κB/PTGS2 signaling axis connects oxidative stress, inflammation, and ferroptosis.
  • Kaempferol demonstrates potential as a therapeutic agent by modulating this pathway to protect melanocytes from ferroptosis.